Non Inferiority,Phase III,Multicentric,Double Blind,Randomized,Parallel Study,Comparing Dolamin Flex (Lysine Clonixinate+Cyclobenzaprine) and Tandrilax(Caffeine +Carisoprodol+Diclofenac+Paracetamol)in Pain Reduction in Patients With Lumbago
Non inferiority, multicentric, double blind study whose the primary objective is to compare the effectiveness of two products in pain reduction. Primary endpoint: reduction in pain average at day 7 compared to day 1(baseline), using Analogue Visual Scale (AVS) for pain evaluation. Secondary endpoint: to evaluate the products safety at the gastrointestinal system.
100 Clinical Results associated with 5-HT2A receptor x ADRA2 x ADRA2B x H1 receptor x α2A-AR x α2C-AR
100 Translational Medicine associated with 5-HT2A receptor x ADRA2 x ADRA2B x H1 receptor x α2A-AR x α2C-AR
0 Patents (Medical) associated with 5-HT2A receptor x ADRA2 x ADRA2B x H1 receptor x α2A-AR x α2C-AR